Position in SNY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$408,128
-$153,265 QoQ
Shares Held
9,567
-17.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#365
of 712 holders
Holding Since
Jun 2023
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Colonial River Investments, LLC holds $5,062,014 across 8 Drug Manufacturers - General names. SNY ranks #7 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
5,439 | $1,368,669 | |
| 2 | JNJ |
Johnson & Johnson
|
3,319 | $842,926 | |
| 3 | LLY |
ELI LILLY & Co
|
500 | $599,715 | |
| 4 | PFE |
Pfizer Inc
|
21,713 | $522,849 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,965 | $500,938 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,226 | $414,541 | |
| 7 | SNY |
Sanofi
This page
|
9,567 | $408,128 | |
| 8 | BIIB |
Biogen Inc.
|
1,871 | $404,248 |
All Filings in SNY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $408,128 | 9,567 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $561,393 | 11,652 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $530,152 | 10,940 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $491,021 | 10,403 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $416,142 | 8,614 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $332,593 | 5,997 | Shares | Sole | 2025-04-25 | |
| 2023-06-30 | $594,301 | 11,026 | Shares | Sole | 2023-08-08 | |
| No filing history on record for this holder in this stock. | ||||||